Tag:
Cempra Pharmaceuticals
Latest Headlines
Latest Headlines
Supernus IPO spotlights perils, potential of going public
Supernus Pharmaceuticals came out of the IPO gate this morning, pricing its shares at a hefty discount in order to complete its long-planned effort to go public.
Osteoporosis drug developer Radius Health braves chilly IPO market
After burning through more than $122 million, the late-stage osteoporosis drug developer Radius Health is filing to go public in the hope of raising up to $86 million. Radius is betting that it can
Antibiotics developer Cempra braves tough market with $86M IPO
Chapel Hill, NC-based Cempra Pharmaceuticals is joining a lineup of biotech companies planning to brave chilly market waters in search of an IPO haul. The biotech has raised a little more than $78
Cempra presents new data on anti-microbials
Cempra Pharmaceuticals gave poster presentations last week on its novel antibiotic CEM-101, a next-generation macrolide, and CEM-102 (TAKSTA), the company's proprietary front-loading oral dosing
Cempra rounds up $46M for antibiotic work
North Carolina-based Cempra Pharmaceuticals has raised a hefty $46 million in a third round of financing. The company is developing two antibiotics for multi-drug resistant bacterial infections. The
